Acomplia Needs More Tests To See If It Helps Diabetes
"Sanofi-Aventis SA, Europe's second- largest drugmaker, needs more tests on weight-loss drug Acomplia to prove the company's claim that the medicine helps obese diabetics control blood sugar levels, researchers said.
A study in today's Lancet that suggests the drug may offer a new approach in diabetes treatment isn't conclusive, Naveed Sattar, a professor at the University of Glasgow, wrote in an accompanying comment. He said the improvement in blood sugar levels may have been caused by factors other than the drug. Sattar wasn't involved in the Sanofi-sponsored study of 1,047 overweight or obese people with type 2 diabetes.
``The results are encouraging, but they leave a number of key questions unanswered,'' Sattar said in a telephone interview. ``More studies are needed to assess the drug's true position in the treatment of diabetes.'' "
acomplia
rimonabant
accomplia
0 Comments:
Post a Comment
<< Home